Medico Remedies Limited (BOM:540937)
India · Delayed Price · Currency is INR 40.65
+2.45 (6.41%)
At close: Jul 27, 2026
Medico Remedies Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,567 | 2,709 | 4,323 | 4,089 | 6,199 | 1,394 | |
Market Cap Growth | 6.02% | -37.35% | 5.72% | -34.03% | 344.64% | 236.00% |
Enterprise Value | 3,721 | 2,816 | 4,422 | 4,084 | 6,330 | 1,488 |
Last Close Price | 42.98 | 32.64 | 52.10 | 49.28 | 74.70 | 16.80 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 27.20 | 20.65 | 42.84 | 49.33 | 85.60 | 28.97 |
PS Ratio | 1.73 | 1.31 | 2.86 | 2.82 | 4.41 | 1.15 |
PB Ratio | 4.73 | 3.59 | 6.92 | 7.81 | 14.14 | 3.81 |
P/TBV Ratio | 4.73 | 3.59 | 6.93 | 7.83 | 14.16 | 3.81 |
P/FCF Ratio | 257.61 | 195.64 | 253.61 | - | 393.61 | - |
P/OCF Ratio | 60.72 | 46.11 | 88.38 | 167.75 | 75.90 | 23.78 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.80 | 1.37 | 2.93 | 2.82 | 4.51 | 1.23 |
EV/EBITDA Ratio | 21.85 | 16.54 | 30.43 | 32.74 | 68.78 | 20.57 |
EV/EBIT Ratio | 26.71 | 20.21 | 36.94 | 40.72 | 91.75 | 28.87 |
EV/FCF Ratio | 268.77 | 203.41 | 259.41 | - | 401.96 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.25 | 0.25 | 0.24 | 0.15 | 0.22 | 0.34 |
Debt / EBITDA Ratio | 1.13 | 1.13 | 0.98 | 0.62 | 1.01 | 1.71 |
Debt / FCF Ratio | 13.87 | 13.87 | 8.62 | - | 6.20 | - |
Net Debt / Equity Ratio | 0.21 | 0.21 | 0.20 | 0.12 | 0.17 | 0.28 |
Net Debt / EBITDA Ratio | 0.91 | 0.91 | 0.84 | 0.52 | 0.82 | 1.42 |
Net Debt / FCF Ratio | 11.16 | 11.16 | 7.13 | -161.00 | 4.82 | -203.03 |
Asset Turnover | 1.51 | 1.51 | 1.40 | 1.58 | 1.70 | 1.58 |
Inventory Turnover | 5.33 | 5.33 | 5.12 | 6.17 | 5.59 | 5.44 |
Quick Ratio | 1.10 | 1.10 | 1.21 | 1.32 | 1.06 | 1.03 |
Current Ratio | 1.66 | 1.66 | 1.70 | 1.72 | 1.55 | 1.51 |
Return on Equity (ROE) | 19.02% | 19.02% | 17.58% | 17.23% | 18.01% | 13.94% |
Return on Assets (ROA) | 6.38% | 6.38% | 6.93% | 6.83% | 5.23% | 4.21% |
Return on Invested Capital (ROIC) | 12.01% | 12.22% | 13.41% | 13.30% | 10.07% | 8.46% |
Return on Capital Employed (ROCE) | 18.40% | 18.40% | 19.10% | 18.80% | 15.10% | 13.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.68% | 4.84% | 2.33% | 2.03% | 1.17% | 3.45% |
FCF Yield | 0.39% | 0.51% | 0.39% | -0.01% | 0.25% | -0.04% |
Buyback Yield / Dilution | -0.03% | -0.03% | - | - | - | - |